ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,997 | -70.9% | 8,969 | -61.3% | 0.00% | -66.7% |
| Q2 2023 | $827,027 | +282.2% | 23,192 | +172.2% | 0.00% | +200.0% |
| Q1 2023 | $216,408 | -73.7% | 8,520 | -58.0% | 0.00% | -75.0% |
| Q4 2022 | $822,962 | +116.6% | 20,290 | +76.5% | 0.00% | +33.3% |
| Q3 2022 | $380,000 | +75.9% | 11,497 | +144.3% | 0.00% | +50.0% |
| Q1 2022 | $216,000 | -78.7% | 4,707 | -69.3% | 0.00% | -80.0% |
| Q4 2021 | $1,016,000 | +12.4% | 15,319 | +5.8% | 0.01% | -9.1% |
| Q3 2021 | $904,000 | -33.4% | 14,485 | -11.6% | 0.01% | -42.1% |
| Q2 2021 | $1,357,000 | +68.8% | 16,383 | +35.1% | 0.02% | +35.7% |
| Q1 2021 | $804,000 | -20.4% | 12,130 | -7.8% | 0.01% | -26.3% |
| Q4 2020 | $1,010,000 | -15.8% | 13,161 | -52.7% | 0.02% | -26.9% |
| Q3 2020 | $1,199,000 | -44.4% | 27,844 | -18.1% | 0.03% | -73.2% |
| Q4 2019 | $2,157,000 | +267.5% | 34,008 | +63.3% | 0.10% | +646.2% |
| Q3 2019 | $587,000 | +162.1% | 20,820 | +77.9% | 0.01% | +62.5% |
| Q3 2018 | $224,000 | – | 11,704 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |